Gut microbiota dysbiosis and bone mineral density in hemodialysis patients: The mediating role of immune-metabolic pathways and clinical implications for nursing care
Acta Microbiologica et Immunologica Hungarica · 2026
DOI: 10.1556/030.2026.02826 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2026. Verfasst von Xunan Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, The Second Medical Center of Chinese PLA General Hospital, 100039, Beijing, China. Hauptthemen laut MEDLINE: Renal Dialysis, Bone Density, Gastrointestinal Microbiome, Dysbiosis. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Nephrology department, The Second Medical Center of Chinese PLA General Hospital.
Abstract (Originalsprache)
The relationship between gut microbiota dysbiosis and bone mineral density (BMD) in hemodialysis patients, mediated through immune-metabolic pathways, remains to be fully elucidated. In this single-center prospective cross-sectional study, 165 maintenance hemodialysis patients were included to evaluate the independent association between gut microbiota composition and BMD, quantify the mediating roles of immune markers and gut-derived metabolites, and assess the effect modification by nursing-modifiable factors. Fecal samples underwent 16S rRNA sequencing and functional prediction. Inflammatory cytokines (IL-6, TNF-α), gut-derived metabolites (indoxyl sulfate, butyrate), and BMD via dual-energy X-ray absorptiometry (DXA) were measured. Gut microbiota community structure significantly differed across BMD tertiles ( R 2 = 0.033, P = 0.003). After full adjustment, principal coordinate 1 (PCoA-PC1, beta-diversity) was negatively associated with femoral neck BMD, while the Shannon diversity index showed a positive association (both P < 0.05). We identified 15 differentially abundant genera between high and low BMD groups. Functional prediction revealed short-chain fatty acid pathways were positively associated with BMD, while indole/p-cresol pathways showed negative associations. Mediation analysis demonstrated that immune markers and gut-derived metabolites collectively explained 45.71% of the microbiota-BMD relationship. Nursing factors significantly modified this association, with the negative relationship strengthened by low fiber intake, severe constipation, proton pump inhibitor use, and inadequate dialysis (Kt/V < 1.4). In conclusion, gut microbiota dysbiosis is independently associated with lower BMD in hemodialysis patients, partially mediated through immune-inflammatory pathways and gut-derived metabolites. Dietary fiber optimization, constipation management, prudent proton pump inhibitor prescribing, and dialysis adequacy represent actionable nursing targets to mitigate gut-mediated bone loss in this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephrology Department, The Second Medical Center of Chinese PLA General Hospital, 100039, Beijing, China.
Förderung
- Nephrology department, The Second Medical Center of Chinese PLA General Hospital
Zitieren
APA
Cheng, X., Pu, S., Wang, Z., Zhang, X., Zuo, M., Ao, Q., & Wu, Z. (2026). Gut microbiota dysbiosis and bone mineral density in hemodialysis patients: The mediating role of immune-metabolic pathways and clinical implications for nursing care. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2026.02826
Vancouver
Cheng X, Pu S, Wang Z, Zhang X, Zuo M, Ao Q, et al. Gut microbiota dysbiosis and bone mineral density in hemodialysis patients: The mediating role of immune-metabolic pathways and clinical implications for nursing care. Acta Microbiologica et Immunologica Hungarica. 2026. doi:10.1556/030.2026.02826
BibTeX
@article{Cheng2026,
author = {Cheng, Xunan and Pu, Shutong and Wang, Zhiying and Zhang, Xiaoyan and Zuo, Manqi and Ao, Qiangguo and Wu, Zhen},
title = {Gut microbiota dysbiosis and bone mineral density in hemodialysis patients: The mediating role of immune-metabolic pathways and clinical implications for nursing care},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2026},
doi = {10.1556/030.2026.02826}
}
EUVIMED